CAS: 694433-59-5; 2-(4-(Benzo[d][1,3]Dioxol-5-yl)-2-(Tert-Butyl)-1H-Imidazol-5-yl)-6-Methylpyridine

该化合物是一个小分子,主要有选择性地抑制了P38中某些成员蛋白活性蛋白体(MAPK)的蛋白体动脉(MAPK),该化合物的特点是能够调节细胞信号路径,这在各种生物过程(包括炎症和应激反应)中至关重要.SB505124已经研究其潜在的治疗应用,特别是在涉及P38MAPK的情形下,例如自发性免疫疾病和癌症.该化合物的特点是其有机溶剂中溶性较低,水溶性较低,从而影响其生物利用率和相合性特性.此外,其分子结构还包括具体的功能组,有助于其与目标动脉结合和选择性.

结构式图片

合成工艺路线路线简述

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ali D, Okla M, Abuelreich S, Vishnubalaji R, Ditzel N, Hamam R, Kowal JM, Sayed A, Aldahmash A, Alajez NM, Kassem M. Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells. Front Endocrinol (Lausanne). 2024 Apr 4;15:1360054. doi: 10.3389/fendo.2024.1360054.
    2: Marín-Aquino LA, Mora-García ML, Moreno-Lafont MC, García-Rocha R, Montesinos-Montesinos JJ, López-Santiago R, Sánchez-Torres LE, Torres-Pineda DB, Weiss-Steider B, Hernández-Montes J, Don-López CA, Monroy-García A. Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF-β1. Cell Biochem Funct. 2024 Apr;42(3):e4010. doi: 10.1002/cbf.4010. 17(3):397. doi: 10.3390/ph17030397.
    4: Du M, Qu Y, Qin L, Zheng J, Sun W. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma. J Cell Mol Med. 2024 Apr;28(7):e18168. doi: 10.1111/jcmm.18168.

    合成参考文献


    参考文献:10.1016/j.bmcl.2015.09.058
    摘要:Krishnaiah M, Jin CH, Sheen YY, Kim D. Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-β type I receptor kinase. Bioorganic & Medicinal Chemistry Letters. 2015 Nov;25(22):5228–31. doi: 10.1016/j.bmcl.2015.09.058.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知